Pharmacoepidemiologist
Epidemiology and Benefit Risk, Sanofi
Dr. Lin Li is a pharmacoepidemiologist with more than 10 years of experience. She has a background in preventive medicine, with PhD training and expertise in pharmacoepidemiology. Currently she is working in Sanofi to support safety of vaccine products from the clinical development program throughout the product lifecycle. Before joining Sanofi in 2018, Dr. Li worked in the Boston Collaborative Drug Surveillance Program, Boston University School of Public Health and Department of Quantitative Health Sciences, University of Massachusetts Medical School. Dr. Li has strong interests in application of advanced methodologies in pharmacoepidemiology and development of guidelines for database studies to generate valid and transparent real-world evidence. She has been involved in the ISPE-funded DIVERSE Initiative and served in the Databases SIG leadership team from 2022 to 2024.